Products

Xelia Bacitracin is composed of a group of polypeptides with antibiotic activity against a variety of Gram-positive bacteria including staphylococci.

Xelia Colistimethate Sodium Lyophilized Vials 150 Mg is a derivative of colistin, which is a mixture of polypeptide antibiotics active against Gram-negative microorganisms: Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and especially Pseudomonas aeruginosa.

Xelia Tobramycin Sulfate is the sulfate salt of tobramycin, an aminoglycoside antibiotic active against Gram-negative bacteria including most Entero-bacteriaceae such as Pseudomonas aeruginosa, and a few Gram-positive bacteria such as Staphylococcus aureus.

Xelia Colistimethate Sodium is a derivative of colistin (polymyxin E) that is a mixture of polypeptide antibiotics active against Gramnegative bacteria, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa.

Xelia Vancomycin Hydrochloride (Copenhage) is a glycopeptide antibiotic active against a wide variety of Gram-positive bacteria, including Clostridium difficile, methicillin resistant (MRSA) and sensitive strains of Staphylococcus aureus (MRSA) and Streptococci.

Xelia Vancomycin Hydrochloride (Budapest) is a glycopeptide antibiotic active against a wide variety of Gram-positive bacteria, including Clostridium difficile, methicillin resistant (MRSA) and sensitive strains of Staphylococcus aureus (MRSA) and Streptococci.

Xelia Gramicidin is a mixture of linear polypeptides active against a variety of Gram-positive bacteria. Application Formulated alone or in combination drug products used in ophthalmic solutions.

Xelia Tyrothricin contains about 20% gramicidin and 80% tyrocidine and belongs to the family of polypeptide antibiotics. It is active against a variety of Gram-positive bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus and bacteria causing diphtheria.

Xelia Bacitracin Vials 50.000 Units is comprised of a polypeptide complex and bacitracin A is the major component in this complex active against a variety of Gram-positive bacteria and a few Gram-negative bacteria, however only staphylococcal infections qualify for the systemic therapy.

Xelia Amphotericin B is a mixture of polyenes active against a wide variety of fungi e.g. Aspergillus, Candida and Cryptococcus species. Applications: Administered intravenously as a colloidal complex with sodium deoxycholate or as a liposomal formulation. The low germ and endotoxin content makes Xellia’s amphotericin B particularly suitable for parenteral use.

Xelia Bacitracin Zinc is composed of a group of polypeptides with antibiotic activity against a variety of Gram-positive bacteria including staphylococci. The zinc complex adds stability to the component, making bacitracin zinc more stable compared to bacitracin.

Xelia Daptomycin is a lipopeptide antibiotic active against Gram-positive bacteria: Such as Staphylococcus aureus (including methicillinresistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp.equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only).

Xelia Colistin Sulfate is a mixture of the sulfates of polypeptide antibiotics active against Gram-negative bacteria.

Xelia Polymyxin B Sulfateis mixture of the sulfates of polypeptide antibiotics active against Pseudomonas aeruginosa and other serious Gram-negative bacteria.

Xelia Colistimethate Sodium Dry-filled Vials 1 Miu, 2 Miu is a derivative of colistin which is a mixture of polypeptide antibiotics active against Gram-negative bacteria, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa.